WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

New Stock Outlook | It is difficult to hide the continued losses with stable income growth, can the new growth curve help Wingspan Technology to "break the deadlock"?

New stock news | Guangdong Topstar Technology (300607.SZ) submits application to Hong Kong Stock Exchange

New Stock News | Wenshi Information Submitted to the Hong Kong Stock Exchange
New Stock Outlook | It is difficult to hide the continued losses with stable income growth, can the new growth curve help Wingspan Technology to "break the deadlock"?

New stock news | Guangdong Topstar Technology (300607.SZ) submits application to Hong Kong Stock Exchange

New Stock News | Wenshi Information Submitted to the Hong Kong Stock Exchange






